Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
Overview
Affiliations
Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence, which is a heterogeneous malignancy with increasing incidence rate and high mortality. For ethical reasons, it is essential to validate medical clinical trials for HCC in animal models before further consideration on humans. Therefore, appropriate models for the study of the pathogenesis of the disease and related treatment methods are necessary. For tumor research, mouse models are the most commonly used and effective model, which is closer to the real-life environment, and the repeated experiments performed on it are closer to the real situation. Several mouse models of HCC have been developed with different mouse strains, cell lines, tumor sites, and tumor formation methods. In this review, we mainly introduce some mouse HCC models, including induced model, gene-edited model, HCC transplantation model, and other mouse HCC models, and discuss how to choose the appropriate model according to the purpose of the experiments.
Kremer K, Khammash H, Miranda A, Rutt L, Twardy S, Anton P Front Immunol. 2025; 15:1497788.
PMID: 39896805 PMC: 11782242. DOI: 10.3389/fimmu.2024.1497788.
Liver Cancer Neuroscience: Regulating Liver Tumors via Selective Hepatic Vagotomy.
Bauer K, Ghabra S, Ma C, Chedester L, Greten T Methods Protoc. 2024; 7(6).
PMID: 39728619 PMC: 11677442. DOI: 10.3390/mps7060099.
Wu R, Chen X, Chen H, Li M, Liang Y Oncol Lett. 2024; 28(6):604.
PMID: 39483968 PMC: 11525613. DOI: 10.3892/ol.2024.14737.
Montagna D, Todero M, Postma G, Trigo R, Bernal A, Bustuoabad O Exp Anim. 2024; 73(4):399-411.
PMID: 39098024 PMC: 11534494. DOI: 10.1538/expanim.23-0149.
Xiang X, Bhowmick K, Shetty K, Ohshiro K, Yang X, Wong L Genes Cancer. 2024; 15():1-14.
PMID: 38323119 PMC: 10843195. DOI: 10.18632/genesandcancer.234.